Name of organisation
1) Department/Research group
2) Organisation/affiliationEvidera
Short Name in the inventoryEvidera
Administrative Contact
Title Dr
Last name Cid
First name Javier
Address line 1Metro Building 6th Floor
Address line 21 Butterwick
Address line 3
CityLondon
PostcodeW6 8DL
CountryUnited Kingdom
Phone number (incl. country code)+34 932 213 441
Alternative phone number+44 (0) 7769 275 683
Fax number (incl. country code)
Scientific Contact
Title Dr
Last name Cid
First name Javier
Address line 1Metro Building 6th Floor
Address line 21 Butterwick
Address line 3
CityLondon
PostcodeW6 8DL
CountryUnited Kingdom
Phone number (incl. country code)+34 932 213 441
Alternative phone number+44 (0) 7769 275 683
Fax number (incl. country code)
2. Description
Evidera partners with life science organizations to optimize the market access and value of their products. The Database Analytics team conducts feasibility studies to provide clients with a critical assessment of the data options available to identify the datasets that will best meet the client’s needs. The team’s epidemiologists extract ‘real-world’ data from existing healthcare information sources and assess, among others, treatment patterns, drug and resource utilization as well as incidence and prevalence of diseases and co-morbidities. Finally, Evidera’s researchers have expertise in using and retrospectively analyzing data from a variety of databases in Europe and compiling database coding algorithms. Evidera’s work lacks the bias that the majority of competitors have based on their association with a single data source and, according to a 2009 survey, its various scientific teams are viewed by biopharmaceutical companies as the best in the industry.
3. Category
For profit organisation
4. Available resources
In houseVia Contacts/Network
5. Therapeutic/disease areas of research in drug safety/risk-benefit performed in the past 5 years
Cardiovascular diseases
Disorders of the central nervous system
Endocrine disorders
Eye disorders
Gastrointestinal tract
Gynaecology
Immunological products and vaccines
Immunosuppression
Liver disease
Malignant disease
Musculoskeletal and joint diseases
Neonates
Pregnancy
Psychiatry
Renal impairment
Respiratory diseases
Skin disorders
Urinary tract disorders
6. Design of drug safety/risk-benefit studies published in the past 5 years
Cohort Study
Case Control Study
Drug Utilisation
Interventional Clinical Trial
Meta-Analysis
7. Experience in collecting data directly from individual patients/respondents
Number of Studies
Greater than 5
Number of patients/respondents involved in the study(ies)
Less than 150
Between 150 and 1499
8. Access to data collection resources
Capacity to conduct face-to-face interviews
Yes
In a clinic
No
In the community
Yes
Electronic data capture systems
No
Interactive voice response systems
No
Call centre
Yes